Cambridge Investment Research Advisors
AMPE

Cambridge Investment Research Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-162
Closed -$44K – 1828
2016
Q4 		$44K Sell
162
-20
-11% -$4.76K ﹤0.01% 1628
2016
Q3 		$41K Buy
+182
New +$51K ﹤0.01% 1707

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Cambridge Investment Research Advisors's AMPE Position: Q1 2017 in Review

Cambridge Investment Research Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2017, closing a stake of 162 shares — an estimated $44K sold.

Cambridge Investment Research Advisors first reported a position in AMPE in Q3 2016 and held it in 2 quarters. The position peaked at $44K in Q4 2016. 64 funds tracked by Wall St. Rank hold AMPE as of Q1 2017.

  • Cambridge Investment Research Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 162 Ampio Pharmaceuticals Inc. shares in Q1 2017, an estimated $44K.
  • Cambridge Investment Research Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q3 2016 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Ampio Pharmaceuticals Inc. position peaked at $44K in Q4 2016.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2017, filed 12 May 2017.